CACNA1H and breast carcinoma: High CACNA1H (Cav3.2) expression levels in ER-positive (ER+) breast cancer are associated with poor prognosis, whereas in HER2-positive (HER2+) breast cancer patients it is associated with better responses to chemotherapy (CT)